PI3K/mTOR Inhibitor-13 sodium

Modify Date: 2025-10-07 11:53:47

PI3K/mTOR Inhibitor-13 sodium Structure
PI3K/mTOR Inhibitor-13 sodium structure
Common Name PI3K/mTOR Inhibitor-13 sodium
CAS Number 2361009-23-4 Molecular Weight 464.40
Density N/A Boiling Point N/A
Molecular Formula C20H13F2N5NaO3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of PI3K/mTOR Inhibitor-13 sodium


PI3K/mTOR Inhibitor-13 sodium is an orally active dual inhibitor of phosphoinositol 3-kinase (PI3K) and mTOR kinase. PI3K/mTOR Inhibitor-13 sodium has potential applications in sexual diseases, solid tumor and idiopathic pulmonary fibrosis (IPF)[1][2].

 Names

Name PI3K/mTOR Inhibitor-13 sodium

 PI3K/mTOR Inhibitor-13 sodium Biological Activity

Description PI3K/mTOR Inhibitor-13 sodium is an orally active dual inhibitor of phosphoinositol 3-kinase (PI3K) and mTOR kinase. PI3K/mTOR Inhibitor-13 sodium has potential applications in sexual diseases, solid tumor and idiopathic pulmonary fibrosis (IPF)[1][2].
Related Catalog
In Vitro PI3K/mTOR Inhibitor-13 sodium (Compound A) (0-2 µM;48 h) 以剂量依赖性方式抑制 HFL1 细胞的增值[1]。 Cell Proliferation Assay[1] Cell Line: HFL1 cells. Concentration: 0, 0.03125, 0.0125, 0.025, 0.05, 0.0625, 0.1, 0.125, 0.2, 0.25, 0.4, 0.5, 1 and 2 µM. Incubation Time: 48 h. Result: Showed inhibitory for HFL1 cells. Western Blot Analysis[1] Cell Line: HFL1 cells. Concentration: 200 nM. Incubation Time: 48 h. Result: Increased the expression of α-SMA/Tubulin.
In Vivo PI3K/mTOR Inhibitor-13 sodium 的药代动力学 (PK) 参数[2] Species Administration manner Dose (mg/kg) T1/2 (h) AUClast (ng•h/mL) Cl/F (L/h/kg) Vss (L/kg) F (%) Rat Intravenous injection 2 2.77 7069 0.29 0.85 94.75 Mice Intravenous injection 1 5.45 57059 0.02 0.13 79.3 Dog Intravenous injection 1 0.67 3672 0.27 0.23 108.5 Monkey Intravenous injection 1 9.70 5978 0.16 0.92 59.8
References

[1]. Cao S, et al. Pharmaceutical combination or pharmaceutical composition for treatment of fibrotic diseases. World Intellectual Property Organization. WO2020078445.

[2]. Xi N, et al. Aromatic heterocyclic compounds, pharmaceutical composition containing compounds and application of pharmaceutical composition.China.CN103965199.

 Chemical & Physical Properties

Molecular Formula C20H13F2N5NaO3S
Molecular Weight 464.40
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.